Deferring percutaneous coronary intervention (PCI) for coronary lesions with fractional flow reserve (FFR) of 0.80 or less is associated with nearly double the risk of cardiovascular events compared with revascularization, new data from the NOTION-3 trial show. 

Tricuspid regurgitation (TR) patients who received transcatheter tricuspid valve annuloplasty (TTVA) with the Cardioband saw positive cardiac remodeling and functional improvement a year post procedurally, according new a new German real-world study. 

Key measurements taken immediately after coronary stent implantation can predict patient outcomes for years to come, according to a new study published in JACC: Cardiovascular Interventions. 

A new imaging technique significantly improves outcomes for patients undergoing transcatheter aortic valve replacement (TAVR) by enhancing visualization of the coronary ostium during valve implantation. 

Findings from the Hispanic Community Health Study/Study of Latinos (HCHS/SOL) suggest that high levels of lipoprotein(a) are linked to an increase in myocardial infarction (MI) cases and all-cause mortality. 

Sodium-glucose cotransporter 2 (SGLT2) inhibitors may reduce the risk of death and hospitalization in patients over 80 years of age with heart failure with preserved ejection fraction (HFpEF), a new expert commentary suggests. 

All 15 members of the U.S. Food and Drug Administration (FDA) advisory panel voted not to proceed with premarket approval (PMA) for the V-Wave™ Ventura Interatrial Shunt System, citing the benefits of the system do not outweigh the risks for patients with heart failure (HF).

Hypertension control on a national scale is possible, according to an initiative that identifies treatment protocols, reliable medication supply, team-based care and strong digital systems to dramatically raise control rates. 

The number of adult heart failure (HF) patients in the U.S. increased from 3.3 million to 7.4 million people over the past 40 years, a new analysis reveals.